The 2022 BCLC model [15] included parameters related to liver function such as albumin-bilirubin score (ALBI) and biomarkers (alpha-fetoprotein, AFP), possibly reflecting HCC malignancy and its ability to metastasize. This evidence concerns the gene AFP and hepatocellular carcinoma.